Linda Friscitia, Yanti Hermayanti, Lilis Mamuroh


In 2012, there were 270,000 women around the world died becouse of cervical cancer. 99.7% of cervical cancers are caused by Human Papilloma Virus (HPV). HPV vaccination programs have been accepted in 77 countries, but around 87% of deaths occured in less developed areas. This study aims to determine the type of HPV vaccine used by both developed and developing countries in managing cervical cancer. This research method is a literature study, with a search using Epidence Based Practice (EBP) from databases such as Pubmed, Proquest, and Google Scholar. There are 10 articles based on searching results using PICO techniques. The instrument is critical appraisal cheklis from JBI QARI. The results of developed countries using this type of vaccine to fight CIN2 / 3 include DNA vaccines, HPV-18.VGX-3100, and AS04-adjuvanted HPV-16/18. Whereas developing countries use an effective type of HPV vaccine to prevent the outbreak of the HPV virus, namely the 2D-AS04-HPV-16/18 vaccine, quadrivalen, HPV-16/18-AS04-adjuvanted. MenACWY-TT, 2D-AS04-HPV-16/18 vaccine can be cost-effective. The conclusion of developed countries has developed a vaccine against CIN2 / 3 HPV-related high-type (16/18). Meanwhile, the developing countries especially in Indonesia just use HPV vaccine to prevent low HPV (6/11). It is suggested for women who will get HPV vaccine to choose an effective vaccine, and health personnel to be able to provide and do counseling about the effective vaccine as a form of cervical cancer prevention.


Vaccine, HPV, Developed Country, Developing Country

Full Text:



Andrijono. (2012). Sinopsis Kanker Ginekologi. Jakarta: Pustaka Spiri

Alfiandhi, I. N., Hermayanti, Y., & Mamuroh, L. (2020). Husbands’attitude of Cervical Cancer Early Detection: IVA Test. Journal of Maternity Care and Reproductive Health, 3(2).

Audina, R., Ermiati, E., & Sukmawati, S. (2019). Women’s Attitude Toward Cervical Cancer Early Detection Using The Via Test Method. Journal of Maternity Care and Reproductive Health, 2(4).

Emilia, O, (2012). Promosi Kesehatan Dalam Lingkup Kesehatan Reproduksi. Yogyakarta: Pustaka Cendekia

Globocan. (2012). Estimatedcancer Incidence, Mortality,Prevalence And Disability-Adjusted Life Years (Dalys) Worldwide In 2008. Iarc Cancer Base No. 11. Diakses Tanggal 18 Maret 2018.

Kemenkes. (2015). Buletin Kanker. Pusat Data Dan Informasi Kementrian Kesehatan Ri

Riksani, R (2016). Kenali Kanker Serviks Sejak Dini. Yogyakarta: Rapha Publishing

Riset Kesehatan Dasar(Riskesdas). (2013). Badan Penelitian Dan Pengembangan Kesehatan Kementerian Ri Tahun 2013.Diakses: 10 Maret 2018, Dari: Http://Www.Depkes.Go.Id/Resources/Download/General/Hasil%20riskesdas%20 2013.Pdf.

S Rachel Skinner, A. S.-P. (2014). Effi cacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Thelancet.

Savitri, Astrid., Et Al. (2015). Kupas Tuntas Kanker Payudara, Leher Rahim & Rahim. Yogyakarta : Pustaka Baru Press.

Sun Kuie Tay, B.-W. L.-H. (2017). Cost-Effectiveness Of Two-Dose Human Papillomavirus Vaccination In Singapore. Singapore Medical Journal, 1-36.

Gebremariam, A., Gebreheat, G., & Jemal, A. (2018). Factors Associated With Cervical Precancerous Lesions Among Women Screened For Cervical Cancer In Addis Ababa, Ethiopia: A Case Control Study. Plos One, 13(1), E0191506.

Wahidin, M. Et Al., (2012). Population-Based Cancer Registration In Indonesia. Asian Pasific Jurnal Of Cancer Prevention: Apjcp, 13(4), Pp.1709-10. Available At: Http Www.Ncbi.Nlm.Nih.Gov/Pubmed/22799393.

Yuliana, M. S. (2013). Evaluasi Program Vaksinasi Kanker Serviks di Kabupaten Badung Tahun 2012. Community Health, 1(3).

DOI: https://doi.org/10.36780/jmcrh.v3i4.145


  • There are currently no refbacks.

Copyright (c) 2021 Journal of Maternity Care and Reproductive Health

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

This Journal is indexed on:

Redaksi Journal of Maternity Care and Reproductive Health:

Fakultas Keperawatan, Universitas Padjadjaran
Jalan Raya Bandung-Sumedang Km. 21 Jatinangor, Sumedang, Indonesia 45363
WA: 081321793280
Email: admin@mcrhjournal.or..id

Creative Commons License
JMCRH is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License